P3 Health Partners Inc. Financial Ratios
PIII|FY2024 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2024 SEC 10-K data.
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2024)
Return on Equity
-95.6%
Profit Margin
-9.1%
Net Income / Revenue
Asset Turnover
2.29
Revenue / Total Assets
Equity Multiplier
4.62
Total Assets / Equity
Composite: -95.6% (reported: -95.6%)
Profitability
Liquidity
Current Ratio
0.24
Quick Ratio
0.24
Solvency
Interest Coverage
4.97
Efficiency
Asset Turnover
2.29
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2024 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
-3.4%
+13.4pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.